Amgen’s famously voracious legal team is living up to its reputation once again, this time with a surprise challenge on the patents surrounding Alexion’s rare diseases blockbuster, Soliris.

Soliris – the most expensive drug in the world – has been recommended by NICE to treat the rare disease aHUS, finally ending a review lasting three years. After a long deliberation, a special ...

New York, March 10, 2025 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) welcomes the U.S. Food and Drug Administration (FDA) approval of the expanded indication of Alexion ...

Significant case: Michael Canty secured a $125 million settlement against Alexion Pharmaceuticals, exposing illegal sales tactics for their blood disorder drug Soliris. He also achieved a $90 ...

While Alexion continues to be viewed as the most respected industry ... positioning it as a likely disruptor to Ultomiris and Soliris upon its introduction. This latest research underscores Spherix’s ...